NEK Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types.
Khoa NguyenJulia BoehlingMinh N TranThomas ChengAndrew RiveraBridgette M Collins-BurowSean B LeeDavid Harold DrewryMatthew E BurowPublished in: Cancers (2023)
The Never in Mitosis Gene A (NIMA)-related kinases (NEKs) are a group of serine/threonine kinases that are involved in a wide array of cellular processes including cell cycle regulation, DNA damage repair response (DDR), apoptosis, and microtubule organization. Recent studies have identified the involvement of NEK family members in various diseases such as autoimmune disorders, malignancies, and developmental defects. Despite the existing literature exemplifying the importance of the NEK family of kinases, this family of protein kinases remains understudied. This report seeks to provide a foundation for investigating the role of different NEKs in malignancies. We do this by evaluating the 11 NEK family kinase gene expression associations with patients' overall survival (OS) from various cancers using the Kaplan-Meier Online Tool (KMPlotter) to correlate the relationship between mRNA expression of NEK1-11 in various cancers and patient survival. Furthermore, we use the Catalog of Somatic Mutations in Cancer (COSMIC) database to identify NEK family mutations in cancers of different tissues. Overall, the data suggest that the NEK family has varying associations with patient survival in different cancers with tumor-suppressive and tumor-promoting effects being tissue-dependent.
Keyphrases
- gene expression
- cell cycle
- dna damage
- case report
- systematic review
- oxidative stress
- papillary thyroid
- protein kinase
- dna methylation
- emergency department
- squamous cell carcinoma
- childhood cancer
- healthcare
- multiple sclerosis
- genome wide
- free survival
- electronic health record
- ejection fraction
- squamous cell
- signaling pathway
- machine learning
- endoplasmic reticulum stress
- mass spectrometry
- big data
- patient reported outcomes
- artificial intelligence
- dna repair
- prognostic factors
- peritoneal dialysis